Thermo Fisher Scientific (TMO) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts TMO Hot Sheet
Price: $706.16 +1.12%
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
COHR, ATS, SICP, More
Financial Fact:
Other Expense, Net: -113.2M
Today's EPS Names:
COHR, ATS, SICP, More
Join SI Premium – FREE
Thermo Fisher Scientific (NYSE: TMO) reported Q4 EPS of $6.10, $0.15 better than the analyst estimate of $5.95. Revenue for the quarter came in at $11.4 billion versus the consensus estimate of $11.29 billion.
For earnings history and earnings-related data on Thermo Fisher Scientific (TMO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vertex (VERX) Tops Q3 EPS by 4c; Offers Guidance
- Veeco Instruments (VECO) Misses Q3 EPS by 9c; Offers Guidance
- Red Violet (RDVT) Tops Q3 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
